sulfinpyrazone has been researched along with Cardiac Diseases in 9 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Excerpt | Relevance | Reference |
---|---|---|
"Aspirin has been shown to reduce the number of transient ischemic attacks (TIA), stroke and death in patients with multiple TIA." | 3.75 | Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. ( Turpie, AG, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perrenoud, JJ | 1 |
Hilliker, KS | 1 |
Roth, RA | 1 |
Castaigne, A | 1 |
Palsky, E | 1 |
Benghozi, R | 1 |
Ledouarin, B | 1 |
Easton, JD | 1 |
Hart, RG | 1 |
Sherman, DG | 1 |
Kaste, M | 1 |
Turpie, AG | 1 |
Barnett, HJ | 1 |
Carter, G | 1 |
Gavin, JB | 1 |
Chamberlain, DA | 1 |
Klotz, H | 1 |
Prohaska, E | 1 |
Salmhofer, H | 1 |
Schmid, L | 1 |
3 reviews available for sulfinpyrazone and Cardiac Diseases
Article | Year |
---|---|
[News in cardiology].
Topics: Heart Diseases; Humans; Myocardial Infarction; Nifedipine; Sulfinpyrazone | 1983 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary | 1982 |
The pathophysiology of transient cerebral ischemic attacks.
Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc | 1979 |
2 trials available for sulfinpyrazone and Cardiac Diseases
Article | Year |
---|---|
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary | 1982 |
Overview of completed sudden death trials: European experience.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Clinical Tri | 1987 |
5 other studies available for sulfinpyrazone and Cardiac Diseases
Article | Year |
---|---|
[Role of medical treatment in the rehabilitation of the coronary patient].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Coronary Disease; Heart Diseases; Humans; Myoc | 1981 |
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogen | 1984 |
Diagnosis and management of ischemic stroke. Part I.--Threatened stroke and its management.
Topics: Anticoagulants; Arrhythmias, Cardiac; Aspirin; Brain Ischemia; Carotid Artery Thrombosis; Cerebral A | 1983 |
Sulphinpyrazone reduces endocardial injury and mural thrombosis.
Topics: Animals; Endocardium; Endothelium; Heart Diseases; Lactates; Male; Microscopy, Electron, Scanning; M | 1990 |
[Gout from the view of a special hospital for rheumatic patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Austria; Child; Cholesterol; Colchicine; Colic; Diabetes Com | 1971 |